Lantern Pharma Cash Flow Statement 2019-2025 | LTRN

Net Income/Loss

$-15.962

$-14.26

$-12.363

$-5.908

$-2.428

Total Depreciation And Amortization - Cash Flow

$-0.159

$0.092

$0.147

$0.003

$0.002

Other Non-Cash Items

$1.235

$2.012

$1.024

$1.192

$0.118

Total Non-Cash Items

$1.077

$2.104

$1.172

$1.196

$0.119

Change In Accounts Receivable

Change In Inventories

Change In Accounts Payable

Change In Assets/Liabilities

$0.774

$-1.192

$-1.022

$-1.056

$-0.192

Total Change In Assets/Liabilities

$0.538

$-0.612

$0.6

$-0.939

$0.181

Cash Flow From Operating Activities

$-14.347

$-12.768

$-10.592

$-5.652

$-2.128

Net Change In Property, Plant, And Equipment

$-0.019

$-0.028

$-0.016

$-0.006

Net Change In Intangible Assets

Net Acquisitions/Divestitures

Net Change In Short-term Investments

$-0.912

$0.207

$-19.515

Net Change In Long-Term Investments

Net Change In Investments - Total

$-0.912

$0.207

$-19.515

Investing Activities - Other

Cash Flow From Investing Activities

$-0.93

$0.179

$-19.531

$-0.016

$-0.006

Net Long-Term Debt

$0.109

Net Current Debt

Debt Issuance/Retirement Net - Total

$0.109

Net Common Equity Issued/Repurchased

$-0.5

$-2.183

$68.2

$26.302

$2.921

Net Total Equity Issued/Repurchased

$-0.5

$-2.183

$68.2

$26.302

$2.921

Total Common And Preferred Stock Dividends Paid

Financial Activities - Other

$-4.784

$-2.745

Cash Flow From Financial Activities

$-0.5

$-2.183

$63.416

$23.665

$2.921

Net Cash Flow

$-15.805

$-14.781

$33.295

$17.997

$0.787

Stock-Based Compensation

$1.068

$1.188

$0.962

$1.192

$0.118

Common Stock Dividends Paid